tiprankstipranks
Trending News
More News >
Wakamoto Pharmaceutical Co., Ltd. (JP:4512)
:4512
Japanese Market
Advertisement

Wakamoto Pharmaceutical Co., Ltd. (4512) Revenue

Compare
0 Followers

Wakamoto Pharmaceutical Co., Ltd. Revenue

Wakamoto Pharmaceutical Co., Ltd. had a revenue of 1.97B in the quarter ending Dec 31, 2023, with 11.94%. This bring the company's revenue in the last twelve months to 7.98B, Increased -3.39%. In the fiscal year ending Mar 31, 2025, Wakamoto Pharmaceutical Co., Ltd. had annual revenue of 7.79B with 0.66% growth.
Revenue (ttm)
7.98B
Revenue Growth
4.00%
P/S Ratio
1.36
Revenue/Employee
¥19,328,690
Employees
403
Market Cap
¥10.62B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 2025
7.79B51.04M+0.66%
Mar 31, 2024
7.74B-921.95M-10.65%
Mar 31, 2023
8.66B277.23M+3.31%
Mar 31, 2022
8.38B-511.69M-5.75%
Mar 31, 2021
8.89B-2.02B-18.53%
Mar 31, 2020
10.92B175.92M+1.64%
Mar 31, 2019
10.74B-158.90M-1.46%
Mar 31, 2018
10.90B67.85M+0.63%
Mar 31, 2017
10.83B
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis